Lantern Pharma (LTRN), Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform

Go back to Lantern Pharma (LTRN), Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform
(NASDAQ: LTRN) Delayed: 1.55 -0.16 (9.36%)
Previous Close $1.71    52 Week High
Open $1.75    52 Week Low
Day High $1.75    P/E N/A 
Day Low $1.55    EPS
Volume 190,533